
Laverock Therapeutics Awarded in Excess of £2.2M Through Two Innovation Grants to Support AI-powered Platform Development and to Expand Therapeutic Programmes Outside of Oncology
<a href="https://news.google.com/rss/articles/CBMi3AJBVV95cUxPeWpwbExOQ280Q2pvQ1Q4TTJWRS1LVFl4UGNpUnRoeUREWHZuMHY5SUd6aUFxbVBlV3hzRFF4c081NV9pSDdQQUdhYmwtckw1RTk3MGQ2SVBiYk1uTkZzLTROSXZNaERLV3FhY1Q5OEhCaHVpajVCeU5NN1hxd0haNEZxOExENFN5UHlBWFRybHVMbVUyTWFaTnMxRThBNV92YUlKTVQ3azJUaHI1V2dDcVZGMi1OdlJ0Y1JMM1llVmg1bWVtb0w2TjhXZXVMM2dBcF8tSjRPWTN4UVo0aC1VT2NkWVU4TnlmcHpPanozazVKX0hyYUp0N3RZc0dCeXdFcTdXc29tSndiQ1Q3cW1sN1J5UG5DZlBuYXhOTkp6d2QtdVFoRDZyNGFhazlTMjVEeTZpbU1OOUUwV0MzX1B4clRzVFVIVXpBYW15MlNxV19VY1ptYXlZbGVGYW4?oc=5" target="_blank">Laverock Therapeutics Awarded in Excess of £2.2M Through Two Innovation Grants to Support AI-powered Platform Development and to Expand Therapeutic Programmes Outside of Oncology</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>
